Clinical and genomic analysis of virulence-related genes in bloodstream infections caused by <i>Acinetobacter baumannii</i>.
Bing BaiBrianna M EalesWei HuangKimberly R LedesmaPaul R MerlauGuiqiu LiZhijian YuVincent H TamPublished in: Virulence (2022)
<i>Acinetobacter baumannii</i> has emerged as a common cause of bloodstream infections, which is associated with high mortality and long periods of hospitalization. To advance the medical care of our patients, the study was designed to identify microbial characteristics associated with poor clinical outcomes. A collection of 32 <i>A. baumannii</i> bloodstream isolates with diverse genetic backgrounds (as determined by multilocus sequence typing) was studied. These isolates were recovered by unique patients (18 males, 14 females; age range: 17 days to 87 years) between 2011 and 2018. A sequential screening approach (cross-referencing analyses using different endpoints) was used to identify isolates with the best correlation between bacterial virulence and clinical prognosis. Isolates associated with more rapid <i>in vitro</i> growth rate, shorter median survival time in pre-clinical infection models, and hospital mortality were selected as candidates for high virulence, while those with opposite characteristics were selected as controls with low virulence. Whole genome sequencing was undertaken in the most promising clinical isolates. We found five virulence genes (beta-hemolysin/cytolysin, Cpi-1a + Cpi-1 (SPI-1 like), enhanced entry proteins, FbpABC, Paa) and 1 secretory system (T6SS) only present in a highly virulent isolate (AB23), compared to a low virulence control isolate (AB6). These genetic elements could be associated with the poor prognosis of <i>A. baumannii</i> bacteraemia and further investigations are warranted.
Keyphrases
- pseudomonas aeruginosa
- acinetobacter baumannii
- escherichia coli
- staphylococcus aureus
- biofilm formation
- antimicrobial resistance
- poor prognosis
- end stage renal disease
- multidrug resistant
- cystic fibrosis
- drug resistant
- ejection fraction
- newly diagnosed
- chronic kidney disease
- healthcare
- genetic diversity
- prognostic factors
- genome wide
- coronary artery disease
- cardiovascular disease
- long non coding rna
- copy number
- cardiovascular events
- microbial community
- patient reported outcomes
- gene expression